Actively Recruiting
Study to Assess Safety and Performance of ABLE Kids Device for Gait Training in Children with Neurological Disorders
Led by ABLE Human Motion S.L. · Updated on 2026-09-08
15
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and clinical performance of the ABLE Kids device in children with neurological gait disorders or muscular weakness. This study aims to gather initial data on the potential clinical and psychosocial benefits of using the device during a structured gait training program. The trial is a pre-post, single-center, quasi-experimental study expected to last about 17 weeks, focusing on pediatric patients up to 17 years old. Participants will undergo a 10-session gait training program using the ABLE Kids exoskeleton device. Training occurs five times per week for up to three weeks, with each session lasting around 60 minutes. The study includes a baseline assessment without the device, followed by the training period and a post-training assessment within one week after the last session. Two weeks later, a follow-up call will check for any adverse events reported after training. Throughout the study, participants will be closely monitored for device safety and performance. Researchers will collect data on adverse events, time to put on and take off the device, walking steps and distance, time spent upright and walking, and assistance needed during sessions. Additional assessments will measure muscle strength, motor functions, balance, pain, exertion, independence, satisfaction, and overall health status. The total study duration includes screening, baseline, training, post-training evaluations, and follow-up over approximately 17 weeks.
CONDITIONS
Brief Title
Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting
Research Team
N
Nuria Maspoch Clemente
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here